Merck KGaA (MKGAF) Short Interest Ratio & Short Volume → Top 5 AI Stocks to Buy for 2024 (From Market Moving Trends) (Ad) Free MKGAF Stock Alerts $175.59 +2.78 (+1.61%) (As of 05/15/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartEarningsHeadlinesShort InterestStock AnalysisChartEarningsHeadlinesShort Interest Merck KGaA Short Interest DataCurrent Short Volume682,700 sharesPrevious Short Volume551,400 sharesChange Vs. Previous Month+23.81%Dollar Volume Sold Short$109.91 millionShort Interest Ratio / Days to Cover1,706.8Last Record DateApril 30, 2024Outstanding Shares129,240,000 sharesPercentage of Shares Shorted0.53%Today's Trading Volume290 sharesAverage Trading Volume912 sharesToday's Volume Vs. Average32% Short Selling Merck KGaA ? Sign up to receive the latest short interest report for Merck KGaA and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMKGAF Short Interest Over TimeMKGAF Days to Cover Over TimeMKGAF Percentage of Float Shorted Over Time Ad Weiss RatingsTiny AI projects with huge promise hiding in plain sight …I’ve developed a system that’s helped me find huge winners in the past. Now my system has alerted me to the next four altcoins that could be the next superstars.Click here to find out who they are. Merck KGaA Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024682,700 shares $109.91 million +23.8%N/A1706.8 $161.00 4/15/2024551,400 shares $89.33 million +4.2%N/A229.8 $162.00 3/31/2024529,000 shares $93.53 million +20.6%N/A881.7 $176.81 3/15/2024438,600 shares $76.69 million +13.4%N/A337.4 $174.86 2/29/2024386,800 shares $65.76 million -3.4%N/A184.2 $170.00 2/15/2024400,300 shares $67.65 million +10.2%N/A444.8 $169.00 Get the Latest News and Ratings for MKGAF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Merck KGaA and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024344,000 shares $53.91 million -5.8%N/A688 $156.73 12/31/2023365,300 shares $58.81 million -18.1%N/A444.9 $161.00 12/15/2023445,800 shares $67.76 million -16.3%N/A40.5 $152.00 11/30/2023532,600 shares $92.14 million +6.6%N/A665.8 $173.00 11/15/2023499,700 shares $84.45 million +25.6%N/A108.6 $169.00 10/31/2023397,900 shares $60.64 million +4.7%N/A137.2 $152.39 10/15/2023379,900 shares $60.31 million +1.1%N/A759.8 $158.75 9/30/2023375,800 shares $62.38 million -6.5%N/A536.9 $166.00 9/15/2023401,800 shares $69.50 million +5.6%N/A669.7 $172.97 8/31/2023380,400 shares $68.66 million +13.7%N/A514.1 $180.50 8/15/2023334,700 shares $59.28 million +2.0%N/A3347 $177.12 7/31/2023328,100 shares $58.07 million -13.0%N/A252.4 $177.00 7/15/2023377,200 shares $63.86 million +20.3%N/A55.5 $169.30 6/30/2023313,600 shares $52.06 million +3.6%N/A627.2 $166.00 6/15/2023302,700 shares $53.58 million +12.2%N/A1513.5 $177.00 5/31/2023269,700 shares $46.93 million +39.2%N/A299.7 $174.00 5/15/2023193,700 shares $34.50 million -29.7%N/A645.7 $178.10 4/30/2023275,700 shares $50.04 million +11.2%N/A919 $181.50 4/15/2023248,000 shares $46.00 million -32.6%N/A496 $185.50 3/31/2023367,900 shares $70.47 million +55.8%N/A1226.3 $191.55 3/15/2023236,200 shares $41.24 million +13.1%N/A787.3 $174.61 2/28/2023208,900 shares $40.00 million -27.5%N/A696.3 $191.50 2/15/2023288,200 shares $57.84 million +27.5%N/A480.3 $200.71 1/31/2023226,000 shares $47.46 million +14.3%N/A205.5 $210.00 1/15/2023197,800 shares $41.90 million +7.6%N/A82.4 $211.85 12/30/2022183,800 shares $35.84 million -0.9%N/A20.2 $195.00 12/15/2022185,400 shares $35.63 million +3.9%N/A206 $192.20 11/30/2022178,500 shares $33.01 million +0.8%N/A595 $184.95 11/15/2022177,100 shares $33.60 million -28.2%N/A126.5 $189.70 10/31/2022246,500 shares $41.73 million +65.6%N/A352.1 $169.30 10/15/2022148,900 shares $24.31 million -12.3%N/A87.6 $163.27 9/30/2022169,700 shares $27.96 million +6.3%N/A565.7 $164.75 9/15/2022159,600 shares $27.04 million -1.2%N/A319.2 $169.45 8/31/2022161,600 shares $28.28 million +63.2%N/A146.9 $175.00Biden to Drop BOMBSHELL June 13th? (Ad)Biden’s days are numbered! According to a former CIA and Pentagon insider… He’s about to drop out of the presidential race on June 13th!Click here now to see his shocking evidence. MKGAF Short Interest - Frequently Asked Questions What is Merck KGaA's current short interest? Short interest is the volume of Merck KGaA shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 682,700 shares of MKGAF short. Learn More on Merck KGaA's current short interest. What is a good short interest ratio for Merck KGaA? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MKGAF shares currently have a short interest ratio of 1,707.0. Learn More on Merck KGaA's short interest ratio. Is Merck KGaA's short interest increasing or decreasing? Merck KGaA saw a increase in short interest in April. As of April 30th, there was short interest totaling 682,700 shares, an increase of 23.8% from the previous total of 551,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Merck KGaA's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Merck KGaA: Alnylam Pharmaceuticals, Inc. (2.08%), Genmab A/S (0.42%), Astellas Pharma Inc. (0.00%), BioMarin Pharmaceutical Inc. (2.06%), Teva Pharmaceutical Industries Limited (1.09%), BeiGene, Ltd. (1.93%), Viatris Inc. (3.84%), Sarepta Therapeutics, Inc. (6.02%), Dr. Reddy's Laboratories Limited (0.52%), United Therapeutics Co. (9.42%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Merck KGaA stock? Short selling MKGAF is an investing strategy that aims to generate trading profit from Merck KGaA as its price is falling. MKGAF shares are trading up $2.78 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Merck KGaA? A short squeeze for Merck KGaA occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MKGAF, which in turn drives the price of the stock up even further. How often is Merck KGaA's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MKGAF, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: ALNY Short Squeeze GMAB Short Squeeze ALPMY Short Squeeze BMRN Short Squeeze TEVA Short Squeeze BGNE Short Squeeze VTRS Short Squeeze SRPT Short Squeeze RDY Short Squeeze UTHR Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:MKGAF) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsTop 5 AI Stocks to Buy for 2024Market Moving TrendsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportPharma Giant Makes Deal with a "Drug Smuggler"Behind the MarketsTop 5 Tech Stocks to Buy for 2024Daily Market Alerts